Showing 7611-7620 of 10402 results for "".
- Outrun The Sun Campaign Launched This Monthhttps://practicaldermatology.com/news/20130502-outrun_the_sun_campaign_launched_this_month/2459552/“Outrun the Sun in May,” a month-long community outreach campaign that encourages people to be both proactive—and active—in terms of skin cancer prevention, launches this month from Outrun the Sun, Inc. Outrun the Sun is partnering with the D
- Slim Fit Lab Coats Boast New Featureshttps://practicaldermatology.com/news/20130430-slim_fit_lab_coats_boast_new_features/2459555/Medelita's line of men's and women's professional lab coats now include iPad lab coat pockets on most styles. Medelita acknowledged dermatologists' frustration with the lack of functionality in standard lab coats by enhancing its features with po
- Me Smooth Debuts on QVChttps://practicaldermatology.com/news/20130429-me_smooth_debuts_on_qvc/2459557/Syneron Beauty Inc. introduced its new me smooth at-home professional hair removal system on QVC this week. The device includes a travel bag and an additional elos cartridge to deliver effective removal of unwanted hair for all skin tones, accordi
- Web‐Based Supply Chain Management Software Launchedhttps://practicaldermatology.com/news/20130418-webbased_supply_chain_management_software_launched/2459562/Aesyntix Health, Inc. launched the Aesyntix Inventory Management (AIM), a web‐based inventory and automated ordering system to enhance its dermatology supply chain management platform. Specifically for dermatology inventory management, AIM helps
- FDA Approves New Corticosteroid Spray for Psoriasishttps://practicaldermatology.com/news/20130415-fda_approves_new_corticosteroid_spray_for_psoriasis/2459564/The FDA has approved Topicort® (desoximetasone) Topical Spray, 0.25%, for the treatment of plaque psoriasis. According manufacturer Taro Pharmaceuticals, Topicort Spray is indicated for patients 18 years of age or older.
- “Dermatologist from the Heart” Program Seeks Grant Proposalshttps://practicaldermatology.com/news/20130410-dermatologist_from_the_heart_program_seeks_grant_proposals/2459567/“Dermatologist from the Heart” is a new program from La Roche-Posay that aims to support initiatives designed to enhance the quality of life for patients. The initiative will award a grant to the most compassionate project spearheaded by dermatologists that seek to enhance patients' quality of life.
- Dr. Yates Hair Science Group Adopts ARTAS Systemhttps://practicaldermatology.com/news/20130410-dr_yates_hair_science_group_adopts_artas_system/2459568/Restoration Robotics, Inc. installed its revolutionary ARTAS® System at the Dr. Yates Hair Science Group. The ARTAS System is the first and only FDA-cleared, physician-controlled, computer-assisted technology for hair transplantation.
- OPTiM Trial Results: New Immunotherapy Study in Melanomahttps://practicaldermatology.com/news/20130409-optim_trial_results_new_immunotherapy_study_in_melanoma/2459569/Results from the Oncovex (GM-CSF) Pivotal Trial in Melanoma (OPTiM) show that a genetically modified version of herpes simplex virus type 1, designated talimogene laherparepvec (T-VEC), shrank melanoma in patients who were in the late stages of the disease. The T-VEC virus works through direct dest
- Rosacea Hinders Social Experiences For More Than 16 Million Americanshttps://practicaldermatology.com/news/20130409-rosacea_hinders_social_experiences_for_more_than_16_million_americans/2459570/Roughly half of rosacea patients refuse certain foods and drinks for fear of triggering a rosacea flare-up. That's according to numbers from the National Rosacea Society (NRS), which designated the month of April as Rosacea Awareness Month to alert the public to the early warning signs of rosacea. T
- Novan Therapeutics: Nitric Oxide May Inhibit Skin Steroidogenesis Locallyhttps://practicaldermatology.com/news/20130408-novan_therapeutics_nitric_oxide_may_inhibit_skin_steroidogenesis_locally/2459571/Novan Therapeutics reports topical nitric oxide-based therapies may reduce androgen levels in the skin by locally inhibiting skin steroidogenesis. The targeted reduction of androgens in the skin could lead to first-in-class local antiandrogen products to treat acne and androgenic alopecia (male patt